BridgeMD
New treatment option for Suicide
Official title TEEM-GIFTS: A Gamified mHealth to Reduce Post-Discharge Suicide Risk
ClinicalTrials.gov ID: NCT06358339
What this study is testing
- What it's testing
- Patients with mental disorders are at significantly higher risk of suicide after discharge compared to the general population and patients with other diseases. Currently, there is a lack of post-discharge community suicide risk management services in China.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- For patients
- Being 18 years and above;
- Being diagnosed with mental disorders;
- Having received inpatient care for three days or more;
- Living in Shenzhen and having no plan to leave Shenzhen in the following 12 months after discharge;
You likely can't join if
- For patients
- Refusing to provide written consent or be unable to provide written consent due to any cognitive problems.
- Being discharged by the patient's or LHSs' demand against medical advice.
- With no ID, no stable residence nor any source of income. For For lay health care supporters (LHSs)
- Refusing to provide written consent. For the clinic and community mental health service providers
- Refusing to provide written consent.
See the full eligibility criteria
- For patients
- Being 18 years and above;
- Being diagnosed with mental disorders;
- Having received inpatient care for three days or more;
- Living in Shenzhen and having no plan to leave Shenzhen in the following 12 months after discharge;
- Being able to use apps or WeChat (WeChat mini program) on smart phones. For lay health care supporters (LHSs)
- Being 18 years and above;
- Being without any diagnosis of mental disorder;
- Being the lay health care supporter in the family;
- Living in Shenzhen and having no plan to leave Shenzhen in the following 12 months after discharge;
- Being able to use apps or WeChat (WeChat mini program) on smart phones. For the clinic and community mental health service providers
- Being 18 years and above;
- Having practiced in mental health service at least for 12 months.
- For patients
- Refusing to provide written consent or be unable to provide written consent due to any cognitive problems.
- Being discharged by the patient's or LHSs' demand against medical advice.
- With no ID, no stable residence nor any source of income. For For lay health care supporters (LHSs)
- Refusing to provide written consent. For the clinic and community mental health service providers
- Refusing to provide written consent.
The study team makes the final eligibility decision.
Where it's taking place
- Shenzhen, Guangdong, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shenzhen, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.